123
Participants
Start Date
May 31, 2008
Primary Completion Date
December 31, 2009
Study Completion Date
January 31, 2012
Abatacept
Subcutaneous injection, 125 mg/mL, once weekly, 48 months
The Center For Rheumatology, Llp, Albany
Local Institution, Mexico City
Rheumatic Disease Associates, Ltd., Willow Grove
Local Institution, Tijuana
The Arthritis Clinic & Carolina Bone & Joint, Charlotte
Unifour Medical Research, Hickory
Arthritis & Rheumatic Disease Specialties, Aventura
Rheumatology Associates Of N. Al, P.C., Huntsville
Graves Gilbert Clinic, Bowling Green
Local Institution, Guadalajara
Cincinnati Rheumatic Disease Study Group, Cincinnati
Diagnostic Rheumatology And Research,Pc, Indianapolis
Local Institution, Nuevo León
Physician Research Collaboration, Llc, Lincoln
Arthritis Centers Of Texas, Dallas
Local Institution, San Luis Potosí City
Walter F. Chase, Md, Austin
Innovative Health Research, Las Vegas
Valerius Medical Group &Research Ctr. Of Greater Long Beach, Long Beach
Inland Rheumatology Clinical Trials Inc., Upland
Allergy & Rheumatology Medical Clinic, Inc., La Jolla
Desert Medical Advances, Palm Desert
Portland Rheumatology Clinic, Lake Oswego
Local Institution, Edmonton
Local Institution, St. John's
Local Institution, Kitchener
Local Institution, Toronto
Local Institution, Montreal
Local Institution, Québec
Local Institution, Mexico City
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY